Aprecia Pharmaceuticals Company:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aprecia Pharmaceuticals Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0470
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aprecia Pharmaceuticals Company (Aprecia) is a drug delivery technology platform company that develops pharmaceutical drug products. The company offers Zipdose technology, a delivery platform that serves as the foundation of orodispersible formulations of prescribed high-dose medications. It also provides 3D printing technology platform that uses an aqueous fluid to stitch together multiple layers of powder using patent-protected process. Aprecia offers SPRITAM levetiracetam tablet for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures in adults and children with epilepsy. The company has operations in Pennsylvania, New Jersey and Ohio, the US. Aprecia is headquartered in Langhorne, Pennsylvania, the US.

Aprecia Pharmaceuticals Company – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aprecia Pharmaceuticals Company, Medical Devices Deals, 2012 to YTD 2018 9
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Aprecia Pharma Raises Funds in Financing Round 11
Aprecia Pharma Raises USD35 Million in Preferred Stock Financing 12
Aprecia Pharma Raises US$15 Million In Venture Financing 13
Aprecia Pharma Raises US$4 Million In Venture Financing 14
Partnerships 15
Aprecia Pharma and Cycle Pharma Enter into Agreement 15
Acquisition 16
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 16
Aprecia Pharmaceuticals Company – Key Competitors 17
Aprecia Pharmaceuticals Company – Key Employees 18
Aprecia Pharmaceuticals Company – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Nov 01, 2017: Aprecia Pharmaceuticals Names University of Kentucky Provost as the Company’s Next CEO 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Key Facts 2
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aprecia Pharmaceuticals Company, Deals By Therapy Area, 2012 to YTD 2018 8
Aprecia Pharmaceuticals Company, Medical Devices Deals, 2012 to YTD 2018 9
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aprecia Pharma Raises Funds in Financing Round 11
Aprecia Pharma Raises USD35 Million in Preferred Stock Financing 12
Aprecia Pharma Raises US$15 Million In Venture Financing 13
Aprecia Pharma Raises US$4 Million In Venture Financing 14
Aprecia Pharma and Cycle Pharma Enter into Agreement 15
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 16
Aprecia Pharmaceuticals Company, Key Competitors 17
Aprecia Pharmaceuticals Company, Key Employees 18
Aprecia Pharmaceuticals Company, Other Locations 19

List of Figures
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aprecia Pharmaceuticals Company, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Aprecia Pharmaceuticals Company:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Owens Corning:企業の戦略・SWOT・財務情報
    Owens Corning - Strategy, SWOT and Corporate Finance Report Summary Owens Corning - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Etex Group Sa
    Etex Group Sa - Strategy, SWOT and Corporate Finance Report Summary Etex Group Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Arsenal Medical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Arsenal Medical Inc (Arsenal) is a platform technology company that develops novel therapeutic polymer based foams. The company’s products include in-situ forming materials, in-situ forming polymeric foam and in-situ curing elastomeric polymer material. It offers in-situ forming materials to …
  • Veristat LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Veristat LLC (Veristat), a subsidiary of Veristat Holding Inc is a clinical research organization that conducts clinical trials. The organization offers services such as clinical project management, data management, clinical monitoring, biostatistics, medical writing, project management, reg …
  • Collegium Pharmaceutical Inc (COLL)-医療機器分野:企業M&A・提携分析
    Summary Collegium Pharmaceutical Inc (Collegium) is a healthcare products provider that develops chronic pain and oral drug delivery solutions. The company's lead candidate, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone that uses DETERx technology for the long-te …
  • salesforce.com, inc.:企業の戦略・SWOT・財務情報
    salesforce.com, inc. - Strategy, SWOT and Corporate Finance Report Summary salesforce.com, inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • E. & J. Gallo Winery:企業の戦略・SWOT・財務情報
    E. & J. Gallo Winery - Strategy, SWOT and Corporate Finance Report Summary E. & J. Gallo Winery - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Otter Tail Corp:企業の発電所・SWOT分析2018
    Otter Tail Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Briscoe Group Ltd (BGP):企業の財務・戦略的SWOT分析
    Briscoe Group Ltd (BGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • STMicroelectronics NV (STM):企業の財務・戦略的SWOT分析
    STMicroelectronics NV (STM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Alexion Pharmaceuticals Inc (ALXN)-製薬・医療分野:企業M&A・提携分析
    Summary Alexion Pharmaceuticals Inc (Alexion) focuses on developing and delivering life-changing drug therapies for patients with serious and ultra-rare disorders. The company develops biologic therapeutic products for the treatment of severe disease states, including genetic diseases, hematologic d …
  • PetroVietnam Fertilizer and Chemicals Corp (DPM):企業の財務・戦略的SWOT分析
    Summary PetroVietnam Fertilizer and Chemicals Corp (PVFCC), formerly Petrovietnam Fertilizer and Chemicals Company, a subsidiary of Vietnam National Oil and Gas Group, is a chemical company that produces and trades specialty chemicals and fertilizers. The company’s products include prilled Urea, NPK …
  • Guangzhou Pharmaceuticals Corp:企業の戦略的SWOT分析
    Guangzhou Pharmaceuticals Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • QGEP Participacoes SA (QGEP3):企業の財務・戦略的SWOT分析
    Summary QGEP Participacoes SA (QGEP), a subsidiary of Queiroz Galvao Group, is an oil and gas company that explores, develops and produces oil and gas properties. The company's exploration properties include Santos Basin, Espirito Santo Basin, Camamu-Almada Basin, Sergipe-Alagoas Basin, Pernambuco-P …
  • AutoNation Inc (AN):企業の財務・戦略的SWOT分析
    AutoNation Inc (AN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Concurrent Technologies Corporation:企業の戦略・SWOT・財務情報
    Concurrent Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Concurrent Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • ET Solar Group Corporation-エネルギー分野:企業M&A・提携分析
    Summary ET Solar Group Corporation (ET Solar) is a provider of renewable energy equipment and services. The company produces a wide variety of photovoltaic (PV) modules based on global standards such as IEC, TUV, VDE, and UL. It also provides horizontally integrated project development; finance and …
  • Mangalore Refinery and Petrochemicals Ltd (MRPL):企業の財務・戦略的SWOT分析
    Mangalore Refinery and Petrochemicals Ltd (MRPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Medical & Biological Laboratories Co Ltd (4557)-医療機器分野:企業M&A・提携分析
    Summary Medical & Biological Laboratories Co Ltd (MBL) is a provider of clinical and basic laboratory diagnostics. The company’s products comprise research reagents, diagnostic reagents and companion diagnostics. It provides diagnostic reagents for therapeutic areas of allergy, antiphospholipid synd …
  • Merrimack Pharmaceuticals Inc (MACK):企業の財務・戦略的SWOT分析
    Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆